tiprankstipranks
Trending News
More News >
BioAge Labs, Inc. (BIOA)
NASDAQ:BIOA
US Market

BioAge Labs, Inc. (BIOA) Financial Statements

Compare
91 Followers

BioAge Labs, Inc. Financial Overview

BioAge Labs, Inc.'s market cap is currently $499.10M. The company's EPS TTM is $-0.56; its P/E ratio is -6.58; BioAge Labs, Inc. is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $-0.77. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00
Operating Income$ -78.19M$ -48.40M$ -39.97M
EBITDA$ -68.58M$ -55.90M$ -39.35M
Net Income$ -71.11M$ -63.85M$ -39.72M
Balance Sheet
Cash & Short-Term Investments$ 354.35M$ 21.64M$ 27.64M
Total Assets$ 358.23M$ 25.92M$ 28.43M
Total Debt$ 8.70M$ 53.25M$ 2.47M
Net Debt$ -345.64M$ 31.61M$ -25.18M
Total Liabilities$ 35.11M$ 199.32M$ 140.99M
Stockholders' Equity$ 323.13M$ -173.40M$ -112.56M
Cash Flow
Free Cash Flow$ -51.89M$ -37.53M$ -36.28M
Operating Cash Flow$ -51.52M$ -37.36M$ -36.18M
Investing Cash Flow$ -366.00K$ -266.00K$ -103.00K
Financing Cash Flow$ 381.20M$ 34.94M$ 2.50M
Currency in USD

BioAge Labs, Inc. Earnings and Revenue History

BioAge Labs, Inc. Debt to Assets

BioAge Labs, Inc. Cash Flow

BioAge Labs, Inc. Forecast EPS vs Actual EPS